Home
Vifor Pharma

Vifor Pharma Market Share Analysis for August 2026

CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.

Health > Biotechnology and Pharmaceuticals

Domainviforpharma.com

Year Founded1933

Employees1001 - 5000

Annual Revenue> $1B

Vifor Pharma

Vifor Pharma (including company regionals)

viforpharma.com

See more website traffic and engagement information

Vifor Pharma Revenue up to August 2026 is > 1B

revenue generated by Vifor Pharma top domains

Vifor Pharma top domains revenue over 3 years

Revenue for Vifor Pharma top domains

viforpharma.com> 1B

See more with Sales Intelligence

Total visits to Vifor Pharma's top domains

Understand Vifor Pharma market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Vifor Pharma's top domains

Analyze Vifor Pharma engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Vifor Pharma's top domains

See how Vifor Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Vifor Pharma top competitors by domain

Top similar sites in August 2026, ranked by their affinity

galenica.comCompany NameGalenicaEmployees5001 - 10000HQSwitzerland, BernAnnual revenue> $1BTotal visits65.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Vifor Pharma

These are the website technologies, by industry, used by Vifor Pharma top domains

Advertising (7)

DoubleClick

Audio Video Media (3)

YouTube

Conversion & Analytics (3)

Google Analytics

Widget (3)

reCAPTCHA

More Technologies

8

See all

News & Signals from Vifor Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVifor Pharma had issues with alleged anti-competitive disparagement of iron deficiency medicine made on Apr 19th '24.Vifor Pharma under investigation for alleged disparagement of rival's iron-deficiency treatment.

NewsWinhealth partnered with Vifor Pharma on Jan 16th '23.Winhealth Pharma today announced that the company has signed a long-term exclusive licensing agreement with Vifor Fresenius Medical Care Renal Pharma (VFMCRP) for the co-development and commercialization of KORSUVA® (difelikefalin) Injection (“i.v. Korsuva”) for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis in China.